GC Asia
Pharming Group reopens EMEA’s CB market
Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company.
JP Morgan was sole global coordinator on the offering, which was launched early on Tuesday morning, and books closed at 11am in London.
Pharming Group’s five year bonds were marketed with an initial coupon range of 2.25% to 3%, and a conversion premium of between 35% and 40%
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
